ID

25888

Descrizione

A 24 week double-blind, randomised, placebo-controlled, parallel-group dose-ranging study to investigate the effects of rosiglitazone (extended release tablets) on cognition in subjects with mild to moderate Alzheimer's disease.

Keywords

versioni (1)
  1. 25/09/17 25/09/17 -
Titolare del copyright

Glaxo Smith Kline

Caricato su

25 settembre 2017

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY-NC 3.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

GSK AVA100193 Rosiglitazone in Alzheimer´s Disease - Study Conclusion

Inglese

Study Conclusion

1 moduli  
  1. StudyEvent: ODM
    1. Study Conclusion
Study Conclusion
Descrizione

Study Conclusion

Alias
UMLS CUI-1
C1707478
UMLS CUI-2
C0008972
Pregnancy Information: Check that responses provided correspond with the sex of the subject.
Descrizione

Monitor Data Validation Check

Tipo di dati

text

Alias
UMLS CUI [1,1]
C1519941
UMLS CUI [1,2]
C1516647
UMLS CUI [1,3]
C0032961
Subject Identifier
Descrizione

Subject Identifier

Tipo di dati

integer

Alias
UMLS CUI [1]
C2348585
Did the subject become pregnant during the study?
Descrizione

Pregnancy

Tipo di dati

text

Alias
UMLS CUI [1]
C0032961
Was the treatment blind broken during the study?
Descrizione

Was the treatment blind broken during the study?

Tipo di dati

text

Alias
UMLS CUI [1,1]
C2347038
UMLS CUI [1,2]
C3897431
Date blind broken
Descrizione

Date blind broken

Tipo di dati

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C3899531
Reason blind broken
Descrizione

Reason blind broken

Tipo di dati

text

Alias
UMLS CUI [1]
C0392360
Specify other reason for unblinding
Descrizione

Reason blind broken

Tipo di dati

text

Alias
UMLS CUI [1,1]
C3897431
UMLS CUI [1,2]
C2347038
UMLS CUI [1,3]
C3845569
A medically qualified Sub-investigator may sign this page; however, the Investigator remains accountable for CRF data.
Descrizione

Investigator Instructions

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0008961
UMLS CUI [1,2]
C1442085
Refer to protocol section(s) (insert protocol section number(s)) to evaluate subject completion or withdrawal from the study. • If subject completed study: Date of subject completion or withdrawal must match the last scheduled study visit date. • If subject withdrew and a withdrawal visit was conducted: Date of subject completion or withdrawal must match the date of subject withdrawal. • If subject lost to follow-up: Date of subject completion or withdrawal must match the last actual contact with the subject whether or not the contact was a clinic visit. Do not record dates of unsuccessful attempts to contact the subject. • Adverse event: includes adverse events, serious adverse events, death (see protocol section 10). • Protocol violation: includes use of prohibited/conditional medications (see protocol section 8.2). • Subject decided to withdraw from the study: includes caregiver decision to withdraw the subject. • Non-compliance: includes non-compliance with study medication (see protocol section 7.11 ), or with study visits/ procedures.
Descrizione

Note: An 'actual contact' is defined as an interaction between the subject and the investigator or investigator's designee, where the investigator/designee has the opportunity to query the subject about the subject's status. This would include clinic visits and telephone contacts, but normally would not include mail correspondence or third party reports.

Tipo di dati

text

Alias
UMLS CUI [1,1]
C1707478
UMLS CUI [1,2]
C0008972
UMLS CUI [1,3]
C1442085
Date of subject completion or withdrawal
Descrizione

Date of subject completion or withdrawal

Tipo di dati

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C0805732
UMLS CUI [1,3]
C2349954
Was the subject withdrawn from the study?
Descrizione

Was the subject withdrawn from the study?

Tipo di dati

text

Alias
UMLS CUI [1]
C0422727
What was the primary reason for withdrawal?
Descrizione

Withdrawal reason

Tipo di dati

text

Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C1549995
If OTHER, please specify
Descrizione

withdrawal reason

Tipo di dati

text

Alias
UMLS CUI [1,1]
C2349954
UMLS CUI [1,2]
C1549995
Investigator Signature
Descrizione

Investigator Signature

Tipo di dati

text

Alias
UMLS CUI [1]
C2346576
Printed Investigators name
Descrizione

Investigator name

Tipo di dati

text

Alias
UMLS CUI [1]
C2826892
Date
Descrizione

Date of completion

Tipo di dati

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C0850287
Ritorna all'inizio della pagina

Similar models

Study Conclusion

1 moduli
  1. StudyEvent: ODM
    1. Study Conclusion
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
Study Conclusion
C1707478 (UMLS CUI-1)
C0008972 (UMLS CUI-2)
Monitor Data Validation Check
Item
Pregnancy Information: Check that responses provided correspond with the sex of the subject.
text
C1519941 (UMLS CUI [1,1])
C1516647 (UMLS CUI [1,2])
C0032961 (UMLS CUI [1,3])
Subject Identifier
Item
Subject Identifier
integer
C2348585 (UMLS CUI [1])
Item
Did the subject become pregnant during the study?
text
C0032961 (UMLS CUI [1])
Pregnancy
Code List
Did the subject become pregnant during the study?
CL Item
No (N)
CL Item
Yes (Complete the Pregnancy Notification form) (Y)
CL Item
Not Applicable (not of childbearing potential or male) (X)
Item
Was the treatment blind broken during the study?
text
C2347038 (UMLS CUI [1,1])
C3897431 (UMLS CUI [1,2])
Was the treatment blind broken during the study?
Code List
Was the treatment blind broken during the study?
CL Item
No (N)
CL Item
Yes (Y)
Date blind broken
Item
Date blind broken
date
C0011008 (UMLS CUI [1,1])
C3899531 (UMLS CUI [1,2])
Item
Reason blind broken
text
C0392360 (UMLS CUI [1])
Reason blind broken
Code List
Reason blind broken
CL Item
Medical emergency requiring identification of investigational product for further treatment (1)
CL Item
Other,specify (2)
Reason blind broken
Item
Specify other reason for unblinding
text
C3897431 (UMLS CUI [1,1])
C2347038 (UMLS CUI [1,2])
C3845569 (UMLS CUI [1,3])
Investigator Instructions
Item
A medically qualified Sub-investigator may sign this page; however, the Investigator remains accountable for CRF data.
text
C0008961 (UMLS CUI [1,1])
C1442085 (UMLS CUI [1,2])
Study Conclusion Investigator Instructions
Item
Refer to protocol section(s) (insert protocol section number(s)) to evaluate subject completion or withdrawal from the study. • If subject completed study: Date of subject completion or withdrawal must match the last scheduled study visit date. • If subject withdrew and a withdrawal visit was conducted: Date of subject completion or withdrawal must match the date of subject withdrawal. • If subject lost to follow-up: Date of subject completion or withdrawal must match the last actual contact with the subject whether or not the contact was a clinic visit. Do not record dates of unsuccessful attempts to contact the subject. • Adverse event: includes adverse events, serious adverse events, death (see protocol section 10). • Protocol violation: includes use of prohibited/conditional medications (see protocol section 8.2). • Subject decided to withdraw from the study: includes caregiver decision to withdraw the subject. • Non-compliance: includes non-compliance with study medication (see protocol section 7.11 ), or with study visits/ procedures.
text
C1707478 (UMLS CUI [1,1])
C0008972 (UMLS CUI [1,2])
C1442085 (UMLS CUI [1,3])
Date of subject completion or withdrawal
Item
Date of subject completion or withdrawal
date
C0011008 (UMLS CUI [1,1])
C0805732 (UMLS CUI [1,2])
C2349954 (UMLS CUI [1,3])
Item
Was the subject withdrawn from the study?
text
C0422727 (UMLS CUI [1])
Was the treatment blind broken during the study?
Code List
Was the subject withdrawn from the study?
CL Item
No (N)
CL Item
Yes (Y)
Item
What was the primary reason for withdrawal?
text
C2349954 (UMLS CUI [1,1])
C1549995 (UMLS CUI [1,2])
Withdrawal reason
Code List
What was the primary reason for withdrawal?
CL Item
Adverse event (record details on the Non-Serious Adverse Event or Serious Adverse Event pages as appropriate) (1)
CL Item
Lost to follow-up (2)
CL Item
Protocol violation (3)
CL Item
Subject decided to withdraw from the study (4)
CL Item
Sponsor terminated study (6)
CL Item
Non-compliance (17)
CL Item
Other, specify (Z)
withdrawal reason
Item
If OTHER, please specify
text
C2349954 (UMLS CUI [1,1])
C1549995 (UMLS CUI [1,2])
Investigator Signature
Item
Investigator Signature
text
C2346576 (UMLS CUI [1])
Investigator name
Item
Printed Investigators name
text
C2826892 (UMLS CUI [1])
Date of completion
Item
Date
date
C0011008 (UMLS CUI [1,1])
C0850287 (UMLS CUI [1,2])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial